Clinical Trial Update: A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing HR17031, INS068, and SHR20004 injections for type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HR17031
• INS068
• SHR20004

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: UNKNOWN